Search - tctmd.com

Displaying 921 - 940 of 1336

Sort: Relevancy | Date

News Conference News TCT 2014

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Yael L. Maxwell

September 19, 2014

News Conference News TCT 2014

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

September 18, 2014

News Conference News TCT 2014

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

September 18, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Industry News

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

September 15, 2014

News Industry News

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Daily News

Valorar los Síntomas Pre-Angiografía y una Toma de Decisiones Compartida son Claves para Mejorar la Conveniencia de las PCI

Yael L. Maxwell

September 02, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

Pre-Angiography Symptom Assessment, Shared Decision Making Key to Improving PCI Appropriateness

Yael L. Maxwell

September 02, 2014

News Daily News

Outlook for Avoiding or Surviving Acute CVD, Stroke Much Improved Over Past Decade

September 02, 2014

Advertisement

Long-term Outcomes Worse for Patients with Coronary Artery Aneurysm After DES Implantation

Real-World Data Show Correlation Between Post-PCI Angina, Resource Utilization

Microvascular Dysfunction Prevalent in Patients with Chest Pain, Non-Obstructive CAD

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

New Study Examines the Optimal Duration Time of Dual Anti-Platelet Therapy in Patients with Second-Generation Drug-Eluting Stents

Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

ABSORB EXTEND: BVS Safe Out to 3 Years

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Valorar los Síntomas Pre-Angiografía y una Toma de Decisiones Compartida son Claves para Mejorar la Conveniencia de las PCI

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

Pre-Angiography Symptom Assessment, Shared Decision Making Key to Improving PCI Appropriateness

Outlook for Avoiding or Surviving Acute CVD, Stroke Much Improved Over Past Decade

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content